Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NEO | Common Stock | Award | $0 | +42K | +39.9% | $0.00 | 147K | Mar 1, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NEO | Stock Option (Right to Buy) | Award | $0 | +103K | $0.00 | 103K | Mar 1, 2022 | Common Stock | 103K | $21.41 | Direct | F4 | |
holding | NEO | Stock Option (Right to Buy) | 63.3K | Mar 1, 2022 | Common Stock | 63.3K | $42.21 | Direct | F3 |
Id | Content |
---|---|
F1 | On March 1, 2022, Ms. Gilbert was granted 42,036 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. |
F2 | This balance includes 97 shares that were acquired at a price of $19.16 per share pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the month ended January 31, 2022. The shares were acquired in transactions exempt from Section 16b-3. |
F3 | On August 17, 2021, Ms. Gilbert was granted 63,331 stock options. These options vest ratably over the first four anniversary dates of the grant date. |
F4 | On March 1, 2022, Ms. Gilbert was granted 102,623 stock options. These options vest ratably over the first four anniversary dates of the grant date. |